Treace Medical Concepts, Inc.

NASDAQ:TMCI

6.9 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -55.743-49.527-42.815-20.552-3.668-4.265
Depreciation & Amortization 8.4195.3522.1330.6851.210.793
Deferred Income Tax 0000.4192.1430.145
Stock Based Compensation 017.3528.1113.4090.9190.815
Change In Working Capital 0-9.743-5.809-1.33-5.319-5.308
Accounts Receivables 0-9.301-11.039-4.226-4.291-6.022
Inventory 0-9.848-8.769-3.088-3.402-2.813
Accounts Payables 03.1674.6121.7911.334-0.236
Other Working Capital -8.4236.2399.3874.1931.043.763
Other Non Cash Items 10.1571.9917.7320.1760.2210.147
Operating Cash Flow -37.167-34.575-30.648-17.193-4.494-7.673
Investing Activities:
Investments In Property Plant And Equipment 0-11.458-14.838-2.705-1.069-1.211
Acquisitions Net 0-2061.68000
Purchases Of Investments 0-169.865-63.409000
Sales Maturities Of Investments 0120.0241.729000
Other Investing Activites 35.3750-61.68000
Investing Cash Flow 35.375-81.299-76.518-2.705-1.069-1.211
Financing Activities:
Debt Repayment 0019.608011.31820
Common Stock Issued 0107.5272.187107.610.3640.068
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.163.7251.198107.6520.185-0.261
Financing Cash Flow 0.16109.38320.806107.65211.50319.739
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -1.632-6.491-86.3687.7545.9410.855
Cash At End Of Period 11.3512.98219.473105.83318.07912.139